ÂÜÀòÂÒÂ×

Dr. Joseph Leveque has over a decade of experience in the development of immuno-oncology therapeutics. He is currently President, Chief Medical Officer, and a Director of Medikine. Prior to Medikine, Joe was Executive Vice President and Chief Medical Officer of Mirati Therapeutics. His previous roles include Chief Medical Officer of Synthorx, a company acquired by Sanofi, and Chief Medical Officer of ARMO Biosciences, an immuno-oncology company acquired by Eli Lilly. Earlier in his career, Joe was Chief Medical Officer of EMD Serono, the North American subsidiary of Merck KGaA, and Vice President and Head of US Medical Oncology at Bristol-Myers Squibb.